Consun Pharmaceutical Group Limited (HKG: 1681)

Consun Pharmaceutical Group Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2,596	2,748	2,450	2,196	1,940	1,383
Short-Term Investments	985.32	834.94	589.17	230	-	-
Cash & Short-Term Investments	3,581	3,583	3,039	2,426	1,940	1,383
Cash Growth	13.25%	17.89%	25.27%	25.05%	40.27%	8.94%
Accounts Receivable	233.46	255.84	259.56	351.23	448.54	763.81
Other Receivables	40.61	54.13	36.1	18.34	9.89	28.44
Receivables	274.06	309.97	295.66	369.57	458.43	792.25
Inventory	364.32	384.91	287.66	257.62	227.37	210.68
Restricted Cash	-	-	-	2.32	-	-
Other Current Assets	23.59	-	-	-	32.62	23.49
Total Current Assets	4,243	4,278	3,623	3,056	2,659	2,410
Property, Plant & Equipment	875.63	863.71	875	858.45	799.45	788.12
Long-Term Investments	19.23	9.23	6.5	-	-	-
Other Intangible Assets	270.7	283.14	311.9	341.66	371.42	396.07
Long-Term Deferred Tax Assets	20.9	17.84	36.43	46.86	58.89	45.94
Other Long-Term Assets	60.21	55.99	39.87	59.94	61.8	68.31
Total Assets	5,490	5,508	4,892	4,363	3,950	3,708
Accounts Payable	41.85	83.1	59.89	66.64	50.89	55.52
Accrued Expenses	607.24	638.76	566.13	465.53	406.42	364.6
Current Portion of Long-Term Debt	507.7	503.42	450.52	599.3	549.41	553.57
Current Portion of Leases	4.12	4.22	3.71	3.12	-	-
Current Income Taxes Payable	34.31	43.38	32.89	2.54	71.11	69.46
Current Unearned Revenue	30.56	17.56	39.98	21.21	15.49	19.25
Other Current Liabilities	160.53	204.57	197.37	199.07	238.55	233.9
Total Current Liabilities	1,386	1,495	1,350	1,357	1,332	1,296
Long-Term Leases	3.6	3.9	5.95	8.55	-	-
Long-Term Unearned Revenue	18.46	19.18	18.93	16.7	15.63	16.74
Long-Term Deferred Tax Liabilities	90.42	71.21	78.01	69.3	86.26	88.29
Total Liabilities	1,499	1,589	1,453	1,452	1,434	1,401
Common Stock	66.86	63.81	63.45	64.8	64.42	68.03
Additional Paid-In Capital	178.77	18.15	-	19.79	-	145.4
Retained Earnings	3,330	3,381	2,913	2,393	2,003	1,640
Treasury Stock	-83.17	-83.17	-83.17	-113.32	-88.64	-88.64
Comprehensive Income & Other	208.78	247.15	251.7	253.89	241.38	228.84
Total Common Equity	3,701	3,627	3,145	2,618	2,220	1,994
Minority Interest	289.73	292.21	293.87	293.08	296.13	312.68
Shareholders' Equity	3,991	3,919	3,439	2,911	2,516	2,307
Total Liabilities & Equity	5,490	5,508	4,892	4,363	3,950	3,708
Total Debt	515.42	511.53	460.18	610.97	549.41	553.57
Net Cash (Debt)	3,066	3,072	2,579	1,815	1,391	829.67
Net Cash Growth	16.82%	19.10%	42.08%	30.52%	67.64%	-5.42%
Net Cash Per Share	3.80	3.84	3.26	2.26	1.70	0.97
Filing Date Shares Outstanding	825.89	792.43	788.39	805.64	799.83	845.73
Total Common Shares Outstanding	825.89	792.43	788.39	805.64	799.83	845.73
Working Capital	2,857	2,783	2,272	1,698	1,327	1,113
Book Value Per Share	4.48	4.58	3.99	3.25	2.78	2.36
Tangible Book Value	3,431	3,343	2,833	2,276	1,849	1,598
Tangible Book Value Per Share	4.15	4.22	3.59	2.83	2.31	1.89
Buildings	-	338.28	334.82	334.1	333.15	332.68
Machinery	-	324.86	302.16	282.15	269	247.23
Construction In Progress	-	416.43	416.01	381.67	314.65	285.92

Source: S&P Capital IQ. Standard template. Financial Sources.